Nama's AI scorecard currently rates Heartflow Sell (4.0 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

When does HTFL report earnings?

Heartflow's next scheduled report is on Nov 12, 2026. Analysts expect EPS of -$0.10.

What is the HTFL price target?

The median analyst price target from 8 analysts is $50.00, with a range of $39.00 – $64.00.

Is HTFL Shariah compliant?

Nama's AAOIFI-style screen reads Heartflow as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.

Nama Insights

Heartflow (HTFL)

Healthcare · Health Information Services · NASDAQ

Heartflow (HTFL) is a Healthcare company in the Health Information Services industry. It has a market capitalization of $4.56B and a free-cash-flow yield of -3.0%. Over the most recent reported fiscal year, revenue grew 39.9%. Nama's AI scorecard rates it Sell, 4.0 out of 10. On 12-month momentum it ranks in the rising band of its market.

AI scorecard

Sell · 4.0/10

Negative, at the mild end of Sell. As of Nov 7, 2026.

Momentum

Rising · +43.1% over 12 months ex. last

Second-best fifth of its market on the past year's move.

Shariah screen

Shariah Compliant

Passes our debt, cash and income screen; not a scholar's ruling.

Off its high

-13.5%

How far the last close sits under the highest price of the past five years.

Market cap	$4.56B
Trailing P/E	—
Price / book	16.2
Price / sales	21.5
FCF yield	-3.0%
Dividend yield	—
Gross margin	80.1%
Operating margin	-34.3%
Net margin	-55.8%
Revenue growth (YoY)	+39.9%
Revenue growth (3-yr annual)	—
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Beta	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Health Information Services

HTFL earnings

Next report: Nov 12, 2026 (Q3 2026, EPS estimate -$0.10). Beat the EPS estimate in 3 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q2 2026	Aug 13, 2026	-$0.07	-$0.13	+46.1%	$64.08M
Q1 2026	May 14, 2026	-$0.16	-$0.17	+5.9%	$52.59M
Q4 2025	Mar 18, 2026	-$0.12	-$0.16	+25.0%	$49.13M
Q3 2025	Nov 12, 2025	-$0.27	-$0.24	-12.5%	$46.28M

HTFL analyst price target

Median target $50.00 from 8 analysts, ranging $39.00 – $64.00.

Health Information Services peers

Ticker	Company	Market cap	P/E
VEEV	Veeva Systems	$49.18B	35.0
TEM	Tempus AI	$13.87B	—
BTSG	BrightSpring Health Services	$13.36B	39.3
HNGE	Hinge Health	$9.34B	51.7
HQY	HealthEquity	$8.57B	23.3
TXG	10x Genomics	$7.72B	296.4
DOCS	Doximity	$5.79B	23.7
WAY	Waystar	$5.45B	17.2

Explore live HTFL data on Nama Insights →

HTFL FAQ

Is HTFL a buy?: Nama's AI scorecard currently rates Heartflow Sell (4.0 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
When does HTFL report earnings?: Heartflow's next scheduled report is on Nov 12, 2026. Analysts expect EPS of -$0.10.
What is the HTFL price target?: The median analyst price target from 8 analysts is $50.00, with a range of $39.00 – $64.00.
Is HTFL Shariah compliant?: Nama's AAOIFI-style screen reads Heartflow as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.